Top compounds associated with response to LINC01125


Feature Type Standardized
Nominal ANOVA
mRNA PX-12 CTRPv2 pan-cancer AAC 0.07 0.01
mRNA BRD-K27188169 CTRPv2 pan-cancer AAC 0.13 0.02
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.02
mRNA Vandetanib CCLE pan-cancer AAC -0.11 0.02
mRNA Erlotinib CCLE pan-cancer AAC -0.11 0.02
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.02
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.02
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC 0.079 0.02
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.09 0.02
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.086 0.02
Download CSV